Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
---|
01/14/2009 | CN101343250A Thrombopoietin mimetics |
01/14/2009 | CN101343240A Preparation method for (2R,3S)-2-hydroxyl-3-amido-3-benzene propanoic methyl ester |
01/14/2009 | CN101343239A Method for separating L-lysine from discharged mother solution from L-cystine preparation |
01/14/2009 | CN101342169A Thrombopoietin mimetics |
01/14/2009 | CN100451014C Process for making chiral 1,4-disubstituted piperazines |
01/13/2009 | US7476762 Reacting trifluoroiodopropane with triphenylphosphine, reacting with a base and ethylchloroformate, reacting with trifluoroacetaldehyde, hydrogenation, reaction with with N,O-dimethylhydroxylamine hydrochloride, reduction, reaction with titanium alkoxide, and (S)-(+)-p-toluenesulfinamide, cyanation |
01/13/2009 | US7476759 Matrix metalloproteinase inhibitors |
01/13/2009 | US7476758 excellent inhibitory activity against alpha 4 integrin-mediated cell adhesion; allergic bronchitis, inflammatory bowel disease, rheumatoid arthritis, experimental autoimmune encephalomyelitis |
01/13/2009 | US7476749 Creatinol-fatty acid esters |
01/08/2009 | WO2009004990A1 Fp receptor agonist |
01/08/2009 | WO2009004643A2 An improved process for preparation of (s)-pregabalin and intermediates thereof |
01/08/2009 | WO2008138621A3 Synthesis of aminocyclopentane carboxylic acids |
01/08/2009 | US20090012306 Cationic Amino Acid Type Lipid |
01/08/2009 | US20090012159 High purity bases of 3,3-diphenylpropylamino monoesters |
01/08/2009 | US20090012141 Composition and Method for Making Oligo-Benzamide Compounds |
01/08/2009 | US20090012129 Novel biaromatic compounds that modulate ppar-receptors |
01/08/2009 | US20090012007 Mimetic Peptides and the Use Thereof in the Form of 20S, 26S and Immunoproteasome Inhitibors |
01/07/2009 | EP2010163A2 Co-crystals of calixarenes and biologically active molecules |
01/07/2009 | CN101341160A Process for production of water-soluble azole prodrug |
01/07/2009 | CN101341119A Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
01/07/2009 | CN101341118A Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
01/07/2009 | CN101341117A Preparation of gamma-amino acids having affinity for the alpha-2-delta protein |
01/07/2009 | CN101337949A Method for synthesizing beta-amido carboxylic acid ester |
01/07/2009 | CN101337903A Method for preparing ethyl levodopa |
01/07/2009 | CN101337902A Desalinisation process for salt-containing water solution of levocarnitine |
01/07/2009 | CN101337901A Method of producing silk tyrosine |
01/06/2009 | US7473801 From an aqueous solution of an alkali metal salt of the amino acid by desalting purification using a moving bed continuous cation exchanger; adsorbing iminodicarboxylic acid by-product to a weakly basic anion exchange resin; crude amino acid passed to the break through point of the anion exchange resin |
01/06/2009 | US7473796 Maytansinoid intermediates: N-alkyl- or aryldithioalkanoylalanines and N-alkanoyl- or aroylthioalkanoylalanines, e.g., N-methyl-N-(4-methyl-4-methyldithio-1-oxopentyl)-alanine; optical isomers and racemic mixtures; preparations from isobutylene sulfide and acetonitrile, methyl methanethiosulfonate, etc. |
01/06/2009 | US7473686 Thrombopoietin mimetics |
01/01/2009 | US20090005562 N-(2,4,6-triisopropylphenylsulfonyl)-3-amidino(or guanidino)phenyl-alanine 4-ethoxycarbonylpiperazide; urokinase inhibitors; reacting a 3-cyanophenylalanine with a quaternary ammonium hydroxide and reacting the product with a phenylsulfonyl halide; industrial scale; simplification; cost efficiency |
12/31/2008 | WO2008115149A8 N-HETEROCYCLIC CARBENE CATALYZED SYNTHESIS OF N-PHENYLISOXAZOLIDIN-5-ONE DERIVATIVE AND SYNTHESIS OF β -AMINO ACID ESTER DERIVATIVE |
12/31/2008 | EP2007711A1 5-aminolevulinic acid salts and their use |
12/31/2008 | EP2007710A1 Preparation of gabapentin by liquid-liquid extraction |
12/31/2008 | EP1896489B1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
12/31/2008 | EP1558230B1 Spirocyclopropyl amides and acids and their therapeutic applications |
12/31/2008 | EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids |
12/31/2008 | CN101333175A Method for preparing D-asparagine and D-homoserine |
12/31/2008 | CN101333171A Method for preparing organic Mannich base accelerant |
12/31/2008 | CN100447152C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
12/31/2008 | CN100447127C Single-component hydrogen-capture-type light initiator and its preparing method and use |
12/30/2008 | US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
12/30/2008 | US7470646 Lewis acid Cu, Zn, Fe, Sc metal compound is confined in a crosslinked copolymer of styrene and 2-[2-phenyl allyloxy] methyl] oxylan; recoverable; as a catalyst in aldol reactions, cyanation, allylation, Michael reactions, Mannich reactions, Diels Alder reactions and Friedel Crafts reactions |
12/30/2008 | CA2387873C Nordihydroguaiaretic derivatives for use in treatment of tumors |
12/30/2008 | CA2186364C Substituted azetidinone compounds useful as hypocholesterolemic agents |
12/29/2008 | CA2636734A1 Metal coordinated compositions |
12/25/2008 | US20080319222 Crystal forms of N- (trans-4-isopropylctyclohexylcarbonyl) -D-phenylalanine |
12/25/2008 | US20080319221 Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids |
12/25/2008 | US20080319076 Compositions comprising creatine salts and methods of use thereof |
12/25/2008 | US20080319075 Polymorphic forms of nateglinide |
12/25/2008 | US20080319074 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses |
12/25/2008 | US20080319064 Deuterium-enriched oseltamivir |
12/25/2008 | US20080319055 Cooling Compounds |
12/25/2008 | US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists |
12/25/2008 | US20080317729 Ammonium Salts and Ammonium Salt/Mineral Salt Clathrate Compounds for Use as Vehicle and Effective Form for Pharmaco-Medical Applications and for Use as Phase Transfer Agents for Chemical Applications |
12/25/2008 | US20080317670 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
12/25/2008 | US20080314107 Salts of Mineral Nutrients Stabilized With Amino Acids and/or Ammonium Salt, Products and Food Supplement That Contain Them and Procedures of Obtention |
12/24/2008 | WO2008157653A1 Deuterium-enriched oseltamivir |
12/24/2008 | WO2008154743A1 Methods for the synthesis of 4-hydroxyisoleucine, stereoisomers and analogs thereof |
12/24/2008 | WO2008124097A3 Salts of isophosphoramide mustard and analogs thereof |
12/24/2008 | EP2006279A1 Method for production of phosphate salt of amino acid |
12/24/2008 | CN101331104A Method for producing optically active (4E)-5-chloro-2-isopropyl-4-pentenoic acid or basic amino acid salt thereof |
12/24/2008 | CN101328131A Process for extracting L-leucine from fermentation liquor by ion exchange technique |
12/24/2008 | CN101328122A Polysubstituted 1-methano-1,2-dihydro naphthalin derivates and preparation thereof |
12/24/2008 | CN100445263C Microwave method for synthesizing carbonate of natrium glycine |
12/23/2008 | CA2422359C Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
12/18/2008 | WO2008152260A2 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
12/18/2008 | WO2008028057A3 Shikimic acid-derived compounds for inhibition and detection of aurora a-associated tumors |
12/18/2008 | US20080312466 New sterospecifc chemical intermediates for statin drugs as astatin side chain building block to allow for a convergent ssynthesis; monoethyl ester of (3R)-acetoxyglutaaric acid chloride; efficiency; |
12/18/2008 | US20080312080 Novel dioctatin derivatives and production process thereof |
12/18/2008 | US20080311635 Process for the preparation of (s)(+)-3-(aminomethyl)-5-methylhexanoic acid |
12/18/2008 | US20080311164 contain a specific N-acylamino acid monoamide monoalkyl ester; do not cause sweating while retaining a practical level of gel strength; good spreadability, and good fittability to skin; antiperspirants |
12/18/2008 | CA2686223A1 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
12/17/2008 | EP0791067B1 Protein kinase npk-110 |
12/17/2008 | CN101326306A Palladium complex and catalyst-imparting treatment solution using the same |
12/17/2008 | CN101326154A Intermediate compounds for the preparation of statins |
12/17/2008 | CN101323581A Synthetic method of beet alkali and beet alkali hydrochlorate |
12/17/2008 | CN100443476C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
12/17/2008 | CN100443466C Cycloalkylaminoacid compounds, processes for making and uses thereof |
12/17/2008 | CN100443463C Substituted p-trifluoromethyl phenyl ether compound and its prepn and application |
12/16/2008 | US7465831 Levalbuterol hydrochloride Polymorph A |
12/16/2008 | US7465825 Phenyl substituted carboxylic acids |
12/16/2008 | US7465820 Abiotic heparin antagonists |
12/11/2008 | WO2008115920A3 Methods for the preparation and formulation of l-carnitine valproate salts |
12/11/2008 | US20080306278 Process |
12/11/2008 | US20080306260 Method for Producing Aryl Amines, Aryl Ethers and Aryl Thioethers |
12/11/2008 | US20080306240 Process for Amination of Acrylic Macromonomers and Products Therefrom |
12/11/2008 | US20080306158 Methods to Prevent Cytotoxicity Using N-Acetyl-Cysteine |
12/11/2008 | US20080306150 Compounds for the Treatment of Metabolic Disorders |
12/11/2008 | US20080305528 Isolation of nucleic acids |
12/11/2008 | US20080305477 Novel Iminecalixarene Derivatives and Aminocalixarene Derivatives, Method of Preparation Thereof, and Self-Assembled Monolayer Prepared by the Method, Fixing Method of Oligo-Dna By Using the Self-Assembled Monolayer, and Oligo-Dna Chip Prepared By the Method |
12/11/2008 | US20080305151 Dipeptide-Comprising Composition for Oral Administration |
12/11/2008 | US20080304867 Image bearing member, method of manufacturing the same, image formation method, image forming apparatus and process cartridge |
12/10/2008 | EP1999136A1 Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use |
12/10/2008 | EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
12/09/2008 | US7462746 Amino polyols and amino sugars |
12/09/2008 | US7462738 Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
12/09/2008 | US7462735 e.g. 4-[4-(hydroxybenzoylamino)benzoylamino]butanoic acid; antithrombotic, antiinflammatory, anticarcinogenic agent, antiallergen; mixture with heparin or glycosaminoglycan oligosaccharides; increase the oral absorption of heparin |
12/09/2008 | US7462644 Therapy for lipid disorders; dyslipidemia; insulin resistance; antidiabetic agents; 4-(2-(((2,6-dichlorophenyl)methyl)thio)ethyl) amino)-2-oxoethoxxy methoxybenzenepropanoic acid |
12/09/2008 | US7462368 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate |